8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Dec 11, 2019 · 6y ago · Accession 0001104659-19-071854
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Armata Pharmaceuticals, Inc.
- Ticker
- ARMP
- CIK
- 921114
- Form type
- 8-K
- Filing date
- Dec 11, 2019
- Report date
- Dec 10, 2019
- Document
- tm1924941d1_8k.htm
- Size
- 154 KB